These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27001857)

  • 1. Suramin inhibits cullin-RING E3 ubiquitin ligases.
    Wu K; Chong RA; Yu Q; Bai J; Spratt DE; Ching K; Lee C; Miao H; Tappin I; Hurwitz J; Zheng N; Shaw GS; Sun Y; Felsenfeld DP; Sanchez R; Zheng JN; Pan ZQ
    Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2011-8. PubMed ID: 27001857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Cullin-RING E3 ubiquitin ligase-dependent ubiquitination by small molecule compounds.
    Wu K; DeVita RJ; Pan ZQ
    J Biol Chem; 2024 Mar; 300(3):105752. PubMed ID: 38354780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid E2-E3 assembly and disassembly enable processive ubiquitylation of cullin-RING ubiquitin ligase substrates.
    Kleiger G; Saha A; Lewis S; Kuhlman B; Deshaies RJ
    Cell; 2009 Nov; 139(5):957-68. PubMed ID: 19945379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity.
    Van Sant C; Hagglund R; Lopez P; Roizman B
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8815-20. PubMed ID: 11447293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suramin and NF449 are IP5K inhibitors that disrupt inositol hexakisphosphate-mediated regulation of cullin-RING ligase and sensitize cancer cells to MLN4924/pevonedistat.
    Zhang X; Shi S; Su Y; Yang X; He S; Yang X; Wu J; Zhang J; Rao F
    J Biol Chem; 2020 Jul; 295(30):10281-10292. PubMed ID: 32493769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of mono- and poly-ubiquitination: Ubiquitination specificity depends on compatibility between the E2 catalytic core and amino acid residues proximal to the lysine.
    Sadowski M; Sarcevic B
    Cell Div; 2010 Aug; 5():19. PubMed ID: 20704751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation- and Skp1-independent in vitro ubiquitination of E2F1 by multiple ROC-cullin ligases.
    Ohta T; Xiong Y
    Cancer Res; 2001 Feb; 61(4):1347-53. PubMed ID: 11245432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
    Lamsoul I; Uttenweiler-Joseph S; Moog-Lutz C; Lutz PG
    Biochimie; 2016 Mar; 122():339-47. PubMed ID: 26253693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functions.
    Cai W; Yang H
    Cell Div; 2016; 11():7. PubMed ID: 27222660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of lysine 48-linked ubiquitin-chain synthesis by the cullin-RING ubiquitin-ligase complex SCF-Cdc34.
    Petroski MD; Deshaies RJ
    Cell; 2005 Dec; 123(6):1107-20. PubMed ID: 16360039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes.
    Hagglund R; Van Sant C; Lopez P; Roizman B
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):631-6. PubMed ID: 11805320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme.
    Ceccarelli DF; Tang X; Pelletier B; Orlicky S; Xie W; Plantevin V; Neculai D; Chou YC; Ogunjimi A; Al-Hakim A; Varelas X; Koszela J; Wasney GA; Vedadi M; Dhe-Paganon S; Cox S; Xu S; Lopez-Girona A; Mercurio F; Wrana J; Durocher D; Meloche S; Webb DR; Tyers M; Sicheri F
    Cell; 2011 Jun; 145(7):1075-87. PubMed ID: 21683433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cullin RING ligases.
    Hotton SK; Callis J
    Annu Rev Plant Biol; 2008; 59():467-89. PubMed ID: 18444905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cdc34 C-terminal tail phosphorylation regulates Skp1/cullin/F-box (SCF)-mediated ubiquitination and cell cycle progression.
    Sadowski M; Mawson A; Baker R; Sarcevic B
    Biochem J; 2007 Aug; 405(3):569-81. PubMed ID: 17461777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start?
    Yu Q; Sun Y
    Drug Des Devel Ther; 2021; 15():1-8. PubMed ID: 33442232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Strategy to Track Lysine-48 Ubiquitination by Fluorescence Resonance Energy Transfer.
    Wu K; Pan ZQ
    Methods Mol Biol; 2021; 2267():91-102. PubMed ID: 33786787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases.
    Furukawa M; He YJ; Borchers C; Xiong Y
    Nat Cell Biol; 2003 Nov; 5(11):1001-7. PubMed ID: 14528312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the Cullin7 E3 ubiquitin ligase--heterodimerization of cullin substrate receptors as a novel mechanism to regulate cullin E3 ligase activity.
    Ponyeam W; Hagen T
    Cell Signal; 2012 Jan; 24(1):290-5. PubMed ID: 21946088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proximity-induced activation of human Cdc34 through heterologous dimerization.
    Gazdoiu S; Yamoah K; Wu K; Escalante CR; Tappin I; Bermudez V; Aggarwal AK; Hurwitz J; Pan ZQ
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15053-8. PubMed ID: 16210246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases.
    Wei D; Morgan MA; Sun Y
    Transl Oncol; 2012 Oct; 5(5):305-12. PubMed ID: 23066438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.